  
    18th Annual
T-Cell Lymphoma Forum

February 4-6, 2027

Loews Coronado Bay Resort
San Diego

Conference rate $279
Reservations must be made by January 6, 2027

Book Hotel

Call for
Scientific
Abstracts

Deadline extended to November 15

Learn more

Call for
Fellows’ Forum
Abstracts

Deadline extended to November 15

Learn more

The 17th Annual T-Cell Lymphoma Forum is the premier global gathering of experts dedicated to advancing the understanding and treatment of T-cell lymphomas. Over two and a half days, the forum will showcase cutting-edge research, emerging therapies, and the latest clinical insights in T-cell lymphoma care.

This year’s agenda features in-depth sessions on molecular pathogenesis, therapeutic innovations, CTCL management, adoptive cellular therapies, and global perspectives on disparities in care. A highlight includes the Fellows Forum, where challenging cases are presented and discussed by leading experts.

Join top scientists, clinicians, and thought leaders in a collaborative environment to tackle pressing challenges and drive progress toward improved patient outcomes.

This activity is not accredited for Continuing Education.

For more information:

uvace@uvahealth.org

Topics include:

Molecular pathogenesis
Therapeutic innovations
CTCL management
Adoptive cellular therapies
Global perspectives on disparities in care

Target audience:

This course has been designed for all clinicians and scientists with an interest in T-cell Lymphoma, including physicians and other healthcare professionals practicing in hematology, oncology, and related fields.